TSX gains after CPI shows US inflation rose 3%
In the world of exchange-traded funds, Cathie Wood’s ARK ETFs stand out for their focus on innovation and disruptive technology. The daily trade report for Wednesday, 22 October 2025, reveals a series of strategic moves by the investment firm, with significant transactions in both buying and selling across various sectors.
Topping the list of ARK’s trades is the purchase of 167,489 shares of Robinhood Markets Inc (NASDAQ:HOOD), valued at approximately $22,081,749. This acquisition was split between the ARKK and ARKW ETFs, with the former purchasing 131,049 shares and the latter 36,440 shares. This move indicates ARK’s growing interest in the fintech space, particularly in companies that are reshaping the brokerage industry.
Another major buy for ARK was Netflix Inc (NASDAQ:NFLX), with 15,756 shares added to the ARKW ETF, totaling a dollar value of $19,558,710. This investment comes at a time when the streaming giant continues to expand its global presence and content library, potentially signaling ARK’s confidence in the company’s growth prospects.
On the sell side, ARK reduced its holdings in Advanced Micro Devices Inc (NASDAQ:AMD) by offloading 44,909 shares through the ARKW ETF, resulting in a transaction value of $10,689,689. This sale might reflect ARK’s portfolio rebalancing or a strategic shift in its view on the semiconductor industry.
Palantir Technologies Inc (NYSE:PLTR) also saw a sell-off, with ARK parting with 23,768 shares through the ARKW ETF, which amounted to $4,314,129. The data analytics firm has been a frequent presence in ARK’s trade reports, suggesting an ongoing evaluation of its position in ARK’s investment strategy.
Other notable sales include 111,849 shares of Roblox Corp (NYSE:RBLX) with a value of $14,893,812 and 55,255 shares of Roku Inc (NASDAQ:ROKU) totaling $5,386,809. These transactions could indicate ARK’s response to market dynamics or shifts in the entertainment and technology sectors.
The report also highlights ARK’s continued divestment of Adaptive Biotechnologies Corp (NASDAQ:ADPT), with 84,986 shares sold for $1,474,507. This follows a similar pattern from last week’s trades, suggesting a strategic reduction in ARK’s exposure to the biotech company.
Other trades included buys in Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) and sales in CareDx Inc (NASDAQ:CDNA), Personalis Inc (NASDAQ:PSNL), Shopify Inc (NYSE:SHOP), and Veracyte Inc (NASDAQ:VCYT), among others.
Investors following ARK’s ETFs will note the firm’s active management approach, as it continues to adjust its holdings in response to market conditions and the evolving landscape of innovation-driven companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.